GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis
NCT07251556
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Psoriasis Arthritis
Interventions
DRUG:
Semaglutide 0.5 mg
DRUG:
Semaglutide 1.0 mg
DRUG:
Semaglutide 0.25 mg
OTHER:
No intervention
Sponsor
Chinese University of Hong Kong